Cargando…
β-nicotinamide mononucleotide (NMN) production in Escherichia coli
Diabetes is a chronic and progressive disease with continuously increasing prevalence, rising financial pressure on the worldwide healthcare systems. Recently, the insulin resistance, hallmark of type 2 diabetes, was cured in mice treated with NAD(+) precursor β-nicotinamide mononucleotide (NMN), no...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095924/ https://www.ncbi.nlm.nih.gov/pubmed/30115969 http://dx.doi.org/10.1038/s41598-018-30792-0 |